Latest Model Idh-1 Monoclonal Antibody Stored At 2~8°c Great Gift Idea [29hIZ8La]

IDH-1 Monoclonal Antibody: A Powerful Tool for Research

IDH-1 Monoclonal Antibody is a highly specialized research tool designed for the detection and analysis of IDH1 gene mutations. This antibody is sourced from rabbits and is specifically reactive against human IDH1 proteins. With its application in Immunohistochemistry (IHC-P), this monoclonal antibody offers a reliable method for identifying IDH1 mutations in various types of gliomas. The IDH1 gene, located at 2q33, encodes isocitrate dehydrogenase 1, and its mutations are commonly found in gliomas. The following list highlights some of the key benefits of using this monoclonal antibody:

• High specificity for human IDH1 proteins
• Applications in IHC-P for glioma diagnosis
• Convenient storage at 2~8°C for long-term stability

Product Features and Specifications

The IDH-1 Monoclonal Antibody is a high-quality research reagent that comes with detailed product specifications. Hosted by rabbits, this antibody is optimized for human IDH1 detection. Its cellular localization is within the cytoplasm, making it suitable for various cellular studies. The antibody is stored at 2~8°C, ensuring its stability and longevity. Below are some of the key features of this monoclonal antibody:

• Host: Rabbit
• Reactivity: Human
• Applications: IHC-P
• Cellular Localization: Cytoplasm
• Storage: 2~8°C, protect from light (Do not freeze)

The IDH-1 Monoclonal Antibody is shipped with ice bags to maintain its integrity during transit, ensuring that it arrives at your laboratory in optimal condition.

Practical Applications in Glioma Research

The identification of IDH1 gene mutations is crucial for glioma diagnosis and prognosis evaluation. The IDH-1 Monoclonal Antibody is a valuable tool for researchers studying the impact of IDH1 mutations on glioma development and treatment. With its high specificity and ease of use, this antibody can help researchers:

• Accurately detect IDH1 mutations in gliomas
• Understand the role of IDH1 mutations in glioma progression
• Develop new diagnostic and therapeutic strategies for gliomas

By choosing the IDH-1 Monoclonal Antibody, you are investing in a reliable and efficient research tool that can significantly advance your glioma research efforts.